Max Healthcare Institute Inkomsten in het verleden
Verleden criteriumcontroles 2/6
Max Healthcare Institute is de winst gegroeid met een gemiddeld jaarlijks percentage van 49.2%, terwijl de Healthcare industrie de winst jaarlijks groeide met 28.3%. De inkomsten zijn gegroeid met een gemiddelde snelheid van 26.1% per jaar. Het rendement op eigen vermogen van Max Healthcare Institute is 12%, en het heeft een nettomarge van 17.7%.
Belangrijke informatie
49.2%
Groei van de winst
46.0%
Groei van de winst per aandeel
Healthcare Groei van de industrie | 29.4% |
Inkomstengroei | 26.1% |
Rendement op eigen vermogen | 12.0% |
Nettomarge | 17.7% |
Volgende winstupdate | 07 Nov 2024 |
Recente prestatie-updates uit het verleden
Recent updates
Shareholders May Be More Conservative With Max Healthcare Institute Limited's (NSE:MAXHEALTH) CEO Compensation For Now
Sep 14Is Max Healthcare Institute (NSE:MAXHEALTH) A Risky Investment?
Jul 18Max Healthcare Institute Limited's (NSE:MAXHEALTH) P/S Is On The Mark
Jun 21Max Healthcare Institute Limited (NSE:MAXHEALTH) Fell Short of Analyst Expectations: Here's What You Need To Know
May 25Here's Why We Think Max Healthcare Institute (NSE:MAXHEALTH) Might Deserve Your Attention Today
Apr 14Max Healthcare Institute Limited's (NSE:MAXHEALTH) Earnings Haven't Escaped The Attention Of Investors
Mar 18Revenue Miss: Max Healthcare Institute Limited Fell 21% Short Of Analyst Revenue Estimates And Analysts Have Been Revising Their Models
Feb 03Max Healthcare Institute (NSE:MAXHEALTH) Seems To Use Debt Rather Sparingly
Jan 08Max Healthcare Institute Limited's (NSE:MAXHEALTH) P/E Still Appears To Be Reasonable
Dec 18With EPS Growth And More, Max Healthcare Institute (NSE:MAXHEALTH) Makes An Interesting Case
Oct 26Max Healthcare Institute (NSE:MAXHEALTH) Could Easily Take On More Debt
Sep 20Is Now The Time To Put Max Healthcare Institute (NSE:MAXHEALTH) On Your Watchlist?
Jul 07Max Healthcare Institute (NSE:MAXHEALTH) Could Easily Take On More Debt
Jun 19Pinning Down Max Healthcare Institute Limited's (NSE:MAXHEALTH) P/E Is Difficult Right Now
Apr 11With EPS Growth And More, Max Healthcare Institute (NSE:MAXHEALTH) Makes An Interesting Case
Mar 15Is Max Healthcare Institute (NSE:MAXHEALTH) A Risky Investment?
Feb 22Max Healthcare Institute (NSE:MAXHEALTH) Has A Rock Solid Balance Sheet
Nov 22Here's Why Max Healthcare Institute (NSE:MAXHEALTH) Has Caught The Eye Of Investors
Oct 26Max Healthcare Institute (NSE:MAXHEALTH) Seems To Use Debt Quite Sensibly
Jul 15Here's Why Max Healthcare Institute (NSE:MAXHEALTH) Can Manage Its Debt Responsibly
Mar 09Max Healthcare Institute's (NSE:MAXHEALTH) Solid Profits Have Weak Fundamentals
Nov 24Opbrengsten en kosten
Hoe Max Healthcare Institute geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
---|---|---|---|---|
30 Sep 24 | 59,970 | 10,590 | 12,508 | 0 |
30 Jun 24 | 56,640 | 10,538 | 11,734 | 0 |
31 Mar 24 | 54,060 | 10,576 | 11,169 | 0 |
31 Dec 23 | 51,976 | 10,570 | 11,689 | 0 |
30 Sep 23 | 50,044 | 9,901 | 11,354 | 0 |
30 Jun 23 | 47,807 | 11,708 | 10,201 | 0 |
31 Mar 23 | 45,626 | 11,035 | 9,863 | 0 |
31 Dec 22 | 42,799 | 9,763 | 10,066 | 0 |
30 Sep 22 | 41,143 | 9,437 | 9,753 | 0 |
30 Jun 22 | 39,976 | 6,310 | 8,699 | 0 |
31 Mar 22 | 39,366 | 6,051 | 8,729 | 0 |
31 Dec 21 | 37,978 | 5,510 | 8,230 | 0 |
30 Sep 21 | 36,193 | 4,516 | 7,797 | 0 |
30 Jun 21 | 32,486 | 3,236 | 6,514 | 0 |
31 Mar 21 | 25,080 | -1,375 | 5,657 | 0 |
31 Dec 20 | 27,772 | -1,177 | 2,199 | 0 |
30 Sep 20 | 22,487 | -2,134 | 1,121 | 0 |
30 Jun 20 | 14,849 | -2,681 | -613 | 0 |
31 Mar 20 | 10,590 | 590 | 3,049 | 0 |
31 Dec 19 | 10,081 | 268 | 761 | 0 |
30 Sep 19 | 18,609 | 720 | 549 | 0 |
30 Jun 19 | 17,719 | 360 | 709 | 0 |
31 Mar 19 | 16,939 | -30 | 759 | 0 |
30 Jun 18 | 17,053 | -704 | 765 | 0 |
31 Mar 18 | 17,303 | -302 | 838 | 0 |
31 Mar 17 | 16,085 | -14 | 721 | 0 |
31 Mar 16 | 14,343 | -180 | 698 | 0 |
31 Mar 15 | 7,896 | -381 | 409 | 0 |
31 Mar 14 | 9,445 | -646 | 132 | 0 |
Kwaliteitswinsten: MAXHEALTH heeft hoge kwaliteitsinkomsten.
Groeiende winstmarge: De huidige netto winstmarges (17.7%) MAXHEALTH } zijn lager dan vorig jaar (19.8%).
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: De winst van MAXHEALTH is de afgelopen 5 jaar aanzienlijk gegroeid met 49.2% per jaar.
Versnelling van de groei: De winstgroei van MAXHEALTH over het afgelopen jaar ( 7% ) ligt onder het 5-jarig gemiddelde ( 49.2% per jaar).
Winst versus industrie: De winstgroei MAXHEALTH over het afgelopen jaar ( 7% ) overtrof de Healthcare -sector 30.6%.
Rendement op eigen vermogen
Hoge ROE: Het Rendement op eigen vermogen ( 12% ) van MAXHEALTH wordt als laag beschouwd.